203 related articles for article (PubMed ID: 26396238)
1. Time-resolved in situ assembly of the leukotriene-synthetic 5-lipoxygenase/5-lipoxygenase-activating protein complex in blood leukocytes.
Gerstmeier J; Weinigel C; Rummler S; Rådmark O; Werz O; Garscha U
FASEB J; 2016 Jan; 30(1):276-85. PubMed ID: 26396238
[TBL] [Abstract][Full Text] [Related]
2. BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly.
Garscha U; Voelker S; Pace S; Gerstmeier J; Emini B; Liening S; Rossi A; Weinigel C; Rummler S; Schubert US; Scriba GK; Çelikoğlu E; Çalışkan B; Banoglu E; Sautebin L; Werz O
Biochem Pharmacol; 2016 Nov; 119():17-26. PubMed ID: 27592027
[TBL] [Abstract][Full Text] [Related]
3. An experimental cell-based model for studying the cell biology and molecular pharmacology of 5-lipoxygenase-activating protein in leukotriene biosynthesis.
Gerstmeier J; Weinigel C; Barz D; Werz O; Garscha U
Biochim Biophys Acta; 2014 Sep; 1840(9):2961-9. PubMed ID: 24905297
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the interaction of human 5-lipoxygenase with its activating protein FLAP.
Häfner AK; Gerstmeier J; Hörnig M; George S; Ball AK; Schröder M; Garscha U; Werz O; Steinhilber D
Biochim Biophys Acta; 2015 Nov; 1851(11):1465-72. PubMed ID: 26327594
[TBL] [Abstract][Full Text] [Related]
5. 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes.
Woods JW; Evans JF; Ethier D; Scott S; Vickers PJ; Hearn L; Heibein JA; Charleson S; Singer II
J Exp Med; 1993 Dec; 178(6):1935-46. PubMed ID: 8245774
[TBL] [Abstract][Full Text] [Related]
6. 5-Lipoxygenase-activating protein rescues activity of 5-lipoxygenase mutations that delay nuclear membrane association and disrupt product formation.
Gerstmeier J; Newcomer ME; Dennhardt S; Romp E; Fischer J; Werz O; Garscha U
FASEB J; 2016 May; 30(5):1892-900. PubMed ID: 26842853
[TBL] [Abstract][Full Text] [Related]
7. The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products.
Fischer L; Hornig M; Pergola C; Meindl N; Franke L; Tanrikulu Y; Dodt G; Schneider G; Steinhilber D; Werz O
Br J Pharmacol; 2007 Oct; 152(4):471-80. PubMed ID: 17704828
[TBL] [Abstract][Full Text] [Related]
8. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
9. Increases in 5-lipoxygenase activating protein expression account for enhanced capacity for 5-lipoxygenase metabolism that accompanies differentiation of peripheral blood monocytes into alveolar macrophages.
Coffey MJ; Wilcoxen SE; Peters-Golden M
Am J Respir Cell Mol Biol; 1994 Aug; 11(2):153-8. PubMed ID: 8049076
[TBL] [Abstract][Full Text] [Related]
10. The nuclear membrane leukotriene synthetic complex is a signal integrator and transducer.
Bair AM; Turman MV; Vaine CA; Panettieri RA; Soberman RJ
Mol Biol Cell; 2012 Nov; 23(22):4456-64. PubMed ID: 23015755
[TBL] [Abstract][Full Text] [Related]
11. 5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase.
Abramovitz M; Wong E; Cox ME; Richardson CD; Li C; Vickers PJ
Eur J Biochem; 1993 Jul; 215(1):105-11. PubMed ID: 8344271
[TBL] [Abstract][Full Text] [Related]
12. The Intracellular Localisation and Phosphorylation Profile of the Human 5-Lipoxygenase Δ13 Isoform Differs from That of Its Full Length Counterpart.
Allain EP; Boudreau LH; Flamand N; Surette ME
PLoS One; 2015; 10(7):e0132607. PubMed ID: 26173130
[TBL] [Abstract][Full Text] [Related]
13. A23187-induced translocation of 5-lipoxygenase in osteosarcoma cells.
Kargman S; Vickers PJ; Evans JF
J Cell Biol; 1992 Dec; 119(6):1701-9. PubMed ID: 1469057
[TBL] [Abstract][Full Text] [Related]
14. 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation.
Woods JW; Coffey MJ; Brock TG; Singer II; Peters-Golden M
J Clin Invest; 1995 May; 95(5):2035-46. PubMed ID: 7738170
[TBL] [Abstract][Full Text] [Related]
15. Prolonged exposure to lipopolysaccharide inhibits macrophage 5-lipoxygenase metabolism via induction of nitric oxide synthesis.
Coffey MJ; Phare SM; Peters-Golden M
J Immunol; 2000 Oct; 165(7):3592-8. PubMed ID: 11034360
[TBL] [Abstract][Full Text] [Related]
16. Translocation and leukotriene synthetic capacity of nuclear 5-lipoxygenase in rat basophilic leukemia cells and alveolar macrophages.
Brock TG; McNish RW; Peters-Golden M
J Biol Chem; 1995 Sep; 270(37):21652-8. PubMed ID: 7665580
[TBL] [Abstract][Full Text] [Related]
17. Two- and three-color STORM analysis reveals higher-order assembly of leukotriene synthetic complexes on the nuclear envelope of murine neutrophils.
Schmider AB; Bauer NC; Sunwoo H; Godin MD; Ellis GE; Lee JT; Nigrovic PA; Soberman RJ
J Biol Chem; 2020 Apr; 295(17):5761-5770. PubMed ID: 32152223
[TBL] [Abstract][Full Text] [Related]
18. Cell biology of the 5-lipoxygenase pathway.
Peters-Golden M
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S227-31; discussion S231-2, S247-8. PubMed ID: 9647604
[TBL] [Abstract][Full Text] [Related]
19. Hypertonicity suppresses ionophore-induced product formation and translocation of 5-lipoxygenase in human leukocytes.
Bürkert E; Rådmark O; Samuelsson B; Steinhilber D; Werz O
J Leukoc Biol; 2002 Mar; 71(3):477-86. PubMed ID: 11867685
[TBL] [Abstract][Full Text] [Related]
20. Phorbol ester up-regulates capacities for nuclear translocation and phosphorylation of 5-lipoxygenase in Mono Mac 6 cells and human polymorphonuclear leukocytes.
Werz O; Klemm J; Samuelsson B; Rådmark O
Blood; 2001 Apr; 97(8):2487-95. PubMed ID: 11290614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
